THSTI Files Patent For Peptide-Based Vaccine Candidates Against SARS-CoV-2 Virus

Like
Like Love Haha Wow Sad Angry

THSTI Files Patent for Peptide-based COVID-19 Vaccine Candidate Translational Health Science and Technology Institute (THSTI) files patent for SARS-COV2 spike domain immunogenic peptide-based vaccine candidates. Synthetic peptides that target neutralizing B-cell or T-cell epitopes for developing antibodies against SARS-CoV2 has been identified and synthesized by a  research team supervised by Prof.Gagandeep Kang and led by […]

The post THSTI Files Patent For Peptide-Based Vaccine Candidates Against SARS-CoV-2 Virus appeared first on BioTecNika .Read more at  www.biotecnika.org/2020/07/thsti-files-patent-for-peptide-based-covid-19-vaccine-candidate/

Like
Like Love Haha Wow Sad Angry